Skip to content

Health Cohort Study of the Chinese Migratory Population

Health Cohort Study of the Chinese Migratory Population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102337
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-05-18
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-communicable Chronic Disease

Interventions

Winter Migratory Group:None
Summer Migratory Group:None
Cold-Region Resident Group:None
Tropical-Region Resident Group:None

Sponsors

Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. It meets the definition standards of "winter bird", "summer bird", and people from cold and tropical regions, and will continue to live in Harbin or Hainan in the future. 2. Baseline age >= 60 years old; 3. No serious diseases (end-stage heart failure, kidney failure, liver failure, malignant tumors); 4. Be capable of taking care of oneself in daily life and possess the ability of a natural person; 5. Voluntarily participate in the research and be willing to engage in it for a long time, providing complete follow-up data and biological samples.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction, acute left heart failure, bypass or stent implantation, life-threatening arrhythmias (ventricular tachycardia, ventricular fibrillation, tachycardia or bradycardia arrhythmias that cause syncope), cerebral infarction, spontaneous and traumatic hemorrhage of the brain parenchyma and subarachnoid space within the recent period (within 30 days); 2. Due to surgery, radiotherapy or chemotherapy for malignant tumors within the recent period (30 days); 3. Those who are undergoing chronic treatment with antiretroviral drugs and antipsychotic drugs; 4. Those who are currently participating in other clinical trials; 5. Those who are currently suffering from acute diseases such as influenza or fever; 6. Those who refuse to sign informed consent and retain biological specimens; 7. Researchers believe that those who are not suitable to participate in the experiment for other reasons.

Design outcomes

Primary

MeasureTime frame
Questionnaire survey project;Physical measurement items;Laboratory test items;Clinical examination items;Health outcome assessment;Assessment of Quality of Life;Changes in biomarkers;Environmental exposure indicators;

Countries

China

Contacts

Public ContactYong Ji

Harbin Medical University

yongji@hrbmu.edu.cn+86 451 8660 5225

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 29, 2026